The global bone and joint supplement market was valued at $10.8B in 2021 and is expected to grow by 8.2% by the end of 2030, according to a study published by Growth Market Reports. The global bone & joint health supplements market growth is attributed to the increasing geriatric population and rising incidence of bone and joint diseases among them.
In terms of types, the global bone & joint health supplements market is segmented into calcium, omega-3 fatty acids, vitamin d, vitamin k, glucosamine-chondroitin, collagen, and others. The calcium segment is anticipated to expand at a sustainable CAGR during the forecast period, due to the increasing demand for calcium supplements. Patients with calcium deficiency and hypocalcemia require specific treatment. This treatment involves oral calcium and vitamin D supplements.
Based on forms, the global bone & joint health supplements market is segmented into capsules, tablets/pills, liquid, and powder. The capsules segment is expected to grow at a significant pace during the forecast period, due to the increasing preference for capsule-based health supplements. Nutrients in capsule form are readily digested compared to other supplement forms and are more effectively absorbed by the body.
Based on regions, the market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The market in North America is projected to expand at a significant CAGR during the forecast period, due to the increasing geriatric population in the region. Furthermore, the increasing consumer awareness and massive R&D program for health supplements in the region are anticipated to fuel the market growth.